Skip to content

Newsletter The Edition

Ackman's aura

Bill Ackman's sale of a 10% stake in his funds management business Pershing Square for a whopping price continues his stellar run — but can it last?

Bill Ackman, pictured in 2015 when he was a top investor in Valeant Pharmaceuticals. AP/Richard Drew.